Clinical Trials Logo

Prenatal Stress clinical trials

View clinical trials related to Prenatal Stress.

Filter by:

NCT ID: NCT03615261 Completed - Pregnancy Clinical Trials

Wellness For 2: A Feasibility and Acceptability Pilot

We2-P
Start date: July 30, 2018
Phase: N/A
Study type: Interventional

The investigators are studying strategies and tools that women can use to manage stress and wellness during pregnancy. The purpose of this project is to test a technology-enhanced version of a wellness intervention for women during their pregnancy (the Mothers and Babies course; MB). The technology that the investigators will test includes wearable heart rate sensors, smartphone text message surveys, and intervention materials delivered through text message.

NCT ID: NCT03404141 Recruiting - Prenatal Stress Clinical Trials

Stress Reduction Therapy for Pregnant Women

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Prenatal stress is associated with negative outcomes such as postpartum depression, prematurity or neurodevelopmental delays. The aim of this study is to implement a psychological therapy to reduce stress during pregnancy.

NCT ID: NCT03389178 Recruiting - Prenatal Stress Clinical Trials

Fetal Biomarkers of Chronic Maternal Stress During Pregnancy

FELICITy
Start date: July 1, 2016
Phase: N/A
Study type: Observational [Patient Registry]

The investigators´ main hypothesis is that prenatal stress (PS)- induced programming during fetal and postnatal development is reflected in epigenetic and autonomic nervous system (ANS) biomarkers which can be harnessed for early detection and follow-up of affected children. By integrating multiple non-invasively obtainable sources of information using novel epigenetic, electrophysiologic and statistical approaches, the trial could yield progress in maternal-fetal medicine, offering a more precise and truly personalized prediction and new possibilities for designing interventions to improve neurodevelopmental outcomes of pregnancy affected by PS.

NCT ID: NCT03028857 Active, not recruiting - Child Development Clinical Trials

Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal

Start date: June 12, 2017
Phase: Phase 1
Study type: Interventional

The goal is to determine if providing a nutritional supplement, phosphatidylcholine, to pregnant women improves early brain development with improved brain-related development during the first four years of life. Participating pregnant women will receive either phosphatidylcholine or a placebo from approximately 16 weeks gestation through birth. The primary outcome is the child's behavior at four years of age as reported by the primary caregiver. Secondary outcomes include motor development, socio-emotional development, language development, and cognitive development. Potential contributors beyond the supplement, including maternal stress and placental function will also be assessed.